Claims for Patent: 9,758,789
✉ Email this page to a colleague
Summary for Patent: 9,758,789
Title: | Constructs for expressing transgenes using regulatory elements from setaria ubiquitin genes |
Abstract: | Provided are constructs and methods for expressing a transgene in plant cells and/or plant tissues using the regulatory elements, including the promoters and/or 3\'-UTRs, isolated from Setaria italica ubiquitin genes. |
Inventor(s): | Kumar; Sandeep (Carmel, IN), Asberry; Andrew (Indianapolis, IN) |
Assignee: | Dow AgroSciences LLC (Indianapolis, IN) |
Application Number: | 14/472,969 |
Patent Claims: | 1. A nucleic acid vector comprising a promoter, wherein i) said promoter is operably linked to a polylinker sequence; ii) said promoter is operably linked to a
non-ubiquitin-coding sequence or iii) said promoter is operably linked to a sequence comprising a polylinker sequence and a non-ubiquitin-coding sequence, wherein said promoter comprises SEQ ID NO: 3 or a sequence that has at least 99% sequence identity
with SEQ ID NO: 3 and can initiate transcription of an operably linked coding sequence.
2. The nucleic acid vector of claim 1 wherein said promoter is less than 3kb in length. 3. The nucleic acid vector of claim 1 wherein said promoter consists of SEQ ID NO: 3. 4. The nucleic acid vector of claim 1 further comprising a sequence encoding a selectable marker. 5. The nucleic acid vector of claim 4 wherein said promoter is operably linked to a transgene. 6. The nucleic acid vector of claim 5 wherein the transgene encodes a selectable marker or a gene product conferring insecticidal resistance, herbicide tolerance, nitrogen use efficiency, water use efficiency, or nutritional quality. 7. The nucleic acid vector of claim 1 further comprising a 3' untranslated sequence comprising SEQ ID NO: 6 or a sequence that has at least 99% sequence identity with SEQ ID NO: 6, wherein the 3' untranslated sequence is operably linked to said polylinker or said coding sequence. 8. The nucleic acid vector of claim 1 further comprising a 5' untranslated sequence comprising SEQ ID NO: 13 or a sequence that has at least 99% sequence identity with SEQ ID NO: 13, wherein the 5' untranslated sequence is inserted between, and operably linked to, said promoter sequence and said polylinker or said coding sequence. 9. The nucleic acid vector of claim 1 further comprising a 5' untranslated sequence comprising SEQ ID NO: 14 or a sequence that has at least 99% sequence identity with SEQ ID NO: 14, wherein the 5' untranslated sequence is inserted between, and operably linked to, said promoter sequence and said polylinker or said coding sequence. 10. The nucleic acid vector of claim 9 further comprising an intron sequence inserted after the 5' untranslated sequence. 11. The nucleic acid vector of claim 10 wherein the intron sequence comprises SEQ ID NO: 9 or SEQ ID NO: 10. 12. The nucleic acid vector of claim 1 wherein the promoter consists of a sequence selected from the group consisting of SEQ ID NO: 17, SEQ ID NO: 40, SEQ ID NO: 41 and SEQ ID NO: 42 or a sequence having at least 99% sequence identity with a sequence selected from the group consisting of SEQ ID NO: 17, SEQ ID NO: 40, SEQ ID NO: 41 and SEQ ID NO: 42, said promoter being operably linked to said polylinker or said coding sequence, wherein said promoter can initiate transcription of the operably linked coding sequence. 13. The nucleic acid vector of claim 1 wherein the promoter consists of SEQ ID NO: 40 or SEQ ID NOL 42 wherein said promoter is operably linked to said polylinker or said coding sequence. 14. The nucleic acid vector of claim 1 wherein the promoter consists of SEQ ID NO: 17 or a sequence having at least 99% sequence identity with SEQ ID NO: 17, said promoter being operably linked to said polylinker or said coding sequence, wherein said promoter can initiate transcription of the operably linked coding sequence. 15. The nucleic acid vector of claim 14 further comprising a 3' untranslated sequence comprising SEQ ID NO: 6 or a sequence that has at least 99% sequence identity with SEQ ID NO: 6, wherein the 3' untranslated sequence is operably linked to said polylinker or said coding sequence. 16. A non-Setaria plant comprising a Setariapromoter, wherein said Setaria promoter comprises SEQ ID NO: 3, or a sequence that has at least 99% sequence identity with SEQ ID NO: 3 operably linked to a coding sequence wherein said Setaria promoter can initiate transcription of the operably linked coding sequence. 17. The plant of claim 16 wherein said plant is selected from the group consisting of maize, wheat, rice, sorghum, oats, rye, bananas, sugar cane, soybean, cotton, sunflower, and canola. 18. The plant of claim 16 wherein said plant is Zea mays. 19. The plant of claim 18 wherein the transgene is inserted into the genome of said plant. 20. The plant of claim 16 further comprising a 5' untranslated sequence comprising SEQ ID NO: 13 or a sequence that has at least 99% sequence identity with SEQ ID NO: 13, wherein the 5' untranslated sequence is inserted between, and operably linked to, said Setaria promoter and said transgene. 21. The plant of claim 16 further comprising a 5' untranslated sequence comprising SEQ ID NO: 14 or a sequence that has at least 99% sequence identity with SEQ ID NO: 14, wherein the 5' untranslated sequence is inserted between, and operably linked to, said Setaria promoter and said transgene. 22. The plant of claim 21 further comprising an operably linked intron sequence inserted after the 5' untranslated sequence and before said transgene. 23. The plant of claim 22 wherein the intron sequence comprises SEQ ID NO: 9 or SEQ ID NO: 10. 24. The plant of claim 20 further comprising a 3' untranslated sequence comprising SEQ ID NO: 6 or a sequence that has at least 99% sequence identity with SEQ ID NO: 6, wherein the 3' untranslated sequence is operably linked to said transgene. 25. The plant of claim 16 wherein the Setaria promoter consists of SEQ ID NO: 40, SEQ ID NO: 42 or a sequence having at least 99% sequence identity with SEQ ID NO: 40 or SEQ ID NO: 42, wherein said Setaria promoter is operably linked to said transgene and can initiate transcription of said transgene. 26. The plant of claim 16 wherein the Setaria promoter consists of SEQ ID NO: 17, SEQ ID NO: 41 or a sequence having at least 99% sequence identity with SEQ ID NO: 17 or SEQ ID NO: 41 wherein said Setaria promoter is operably linked to said transgene. 27. The plant of claim 26 further comprising a 3' untranslated sequence comprising SEQ ID NO: 6 or a sequence that has at least 99% sequence identity with SEQ ID NO: 6, wherein the 3' untranslated sequence is operably linked to said transgene. 28. A nucleic acid vector comprising a transcription terminator, wherein i) said terminator is operably linked to a polylinker sequence; ii) said terminator is operably linked to a non-ubiquitin-encoding transgene; or iii) said terminator is operably linked to a sequence comprising a polylinker sequence and a non-ubiquitin-encoding transgene, wherein said transcription terminator comprises SEQ ID NO: 6 or a sequence that has at least 99% sequence identity with SEQ ID NO: 6. 29. The nucleic acid vector of claim 28 wherein said transcription terminator is less than 1kb in length. 30. The nucleic acid vector of claim 29 wherein said transcription terminator consists of SEQ ID NO: 6. |
Details for Patent 9,758,789
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2033-08-30 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2033-08-30 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2033-08-30 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.